Ken Fisher’s Genmab GMAB Stock Holding History

Ken Fisher’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-19	Closed	-$670	–	1040
2023 Q3	$670	Hold	19	–	–	﹤0.01%	1166
2023 Q2	$722	Hold	19	–	–	﹤0.01%	1160
2023 Q1	$717	Buy	+19	New	+$730	﹤0.01%	1129

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ken Fisher's GMAB Position: Q4 2023 in Review

Ken Fisher sold out of Genmab (GMAB) in Q4 2023, closing a stake of 19 shares — an estimated $670 sold.

Ken Fisher first reported a position in GMAB in Q1 2023 and held it in 3 quarters. The position peaked at $722 in Q2 2023. 226 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

Ken Fisher reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
Ken Fisher sold 19 Genmab shares in Q4 2023, an estimated $670.
Ken Fisher first reported a position in Genmab in Q1 2023 and held it in 3 quarters.
Ken Fisher's Genmab position peaked at $722 in Q2 2023.
226 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on Fisher Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.